% | $
Quotes you view appear here for quick access.

Array BioPharma Inc. Message Board

  • tuna_20_25 tuna_20_25 May 30, 2013 5:05 PM Flag

    Here is part os the ASLAN from 5-28-13

    ASLAN Pharmaceuticals announces positive data with ASLAN001 in gastric cancer phase 2 study Singapore, 28 May 2013 – ASLAN Pharmaceuticals Pte Ltd today announced the results of a phase 2 clinical trial with ASLAN001, a small-molecule pan-HER inhibitor, in gastric cancer. ASLAN001 reduced cell proliferation and cell survival in gastric tumours that were either coexpressing EGFR and HER2 or that were HER2 amplified. ASLAN001 was invented by Array BioPharma Inc (NASDAQ: ARRY) and licensed to ASLAN in 2011. “This is the first time a drug has shown activity in this patient population,” said Dr Alan Barge, ASLAN’s Chief

    BIG QUESTION why did ARRY not release a PR ?

3.65-0.04(-1.08%)Sep 23 4:00 PMEDT